ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis. Raza M, Rajan AR, Kennedy BB, Reznicek TE, et al. Oncogene 2025 Sep 4. doi: 10.1038/s41388-025-03559.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Raza M, Rajan AR, Kennedy BB, Reznicek TE, et al. ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis. Oncogene 2025 Sep 4. doi: 10.1038/s41388-025-03559.
PMID: 40908313